Oculus Innovative Sciences (OCLS -4%) slips this morning, despite an earlier announcement that...

|About: Oculus Innovative Sciences,... (OCLS)|By:, SA News Editor

Oculus Innovative Sciences (OCLS -4%) slips this morning, despite an earlier announcement that it had inked an agreement to establish licensing and supply, as well as shared services, with its wholly owned subsidiary, Ruthigen. They will focus on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based therapeutics. The company expects to negotiate a third agreement governing other terms of their business relationship in the near term.